(Q44667729)

5 December 2017

title

Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

5 December 2017

main subject

1 reference

Mulloy E

1

1 reference

5 December 2017

McNicholas WT

series ordinal

2

1 reference

5 December 2017

publication date

1 October 1993

1 reference

The American Review of Respiratory Disease

5 December 2017

published in

1 reference

5 December 2017

volume

148

1 reference

5 December 2017

issue

4 Pt 1

1 reference

5 December 2017

page(s)

1030-1036

1 reference

Management of asthma and chronic airflow limitation. Are methylxanthines obsolete?

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

Overview of effects of theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

Mechanism of respiratory effects of methylxanthines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3',5'-adenosine monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

Effect of theophylline on sleep and sleep-disordered breathing in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

Dose response relation to oral theophylline in severe chronic obstructive airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

Nocturnal asthma therapy. Inhaled bitolterol versus sustained-release theophylline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

Effect of therapeutic theophylline levels on the sleep quality and daytime cognitive performance of normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

THEOPHYLLINE PRESCRIBING, SERUM CONCENTRATIONS, AND TOXICITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_1.1030

10.1164/AJRCCM/148.4_PT_1.1030

21 January 2018

Identifiers

DOI

0 references

1 reference